Demonstrates enhanced toxin removal in hyperbilirubinemia, suggesting novel blood purification materials.
Hyperbilirubinemia, which stems from bilirubin accumulation caused by liver failure, can lead to jaundice, multi‐organ damage, and mortality. Hemoperfusion is the most effective detoxification approach, and its efficacy critically depends on the adsorbent system. However, most developed adsorbents exhibit poor hemocompatibility, posing risks of coagulation and bacterial infection. Herein, we report a facile and highly biocompatible strategy to fabricate bioactive superstructures for blood purification, enabling toxin removal. The formation of the bioactive superstructures is mediated by the assembly of polydopamine/Zn II networks on natural polymer templates, followed by surface modification with human serum albumin. The obtained superstructures enable rapid bilirubin clearance owing to the synergistic effects of metal coordination and polyphenol‐mediated noncovalent interactions (hydrogen bonding and hydrophobic and electrostatic interactions). Furthermore, these bioactive superstructures exhibit excellent antibacterial efficacy, achieving > 99.9% killing efficiency of both Escherichia coli and Staphylococcus aureus , while enhancing anticoagulant performance by 2.6‐fold (compared to the control) through inhibition of platelet adhesion/activation and modulation of the intrinsic coagulation pathway. This work expands our understanding of metal–phenolic‐mediated superstructure assembly. Furthermore, the efficient toxin removal, antibacterial protection, and anticoagulant activity of the developed bioactive superstructures are expected to underpin the rational design of blood‐contacting materials based on metal–phenolic complexation.
No takes yet. Share an insight, caveat, or question.
Po et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: